Successful crizotinib rechallenge after crizotinib-induced interstitial lung disease in patients with advanced non-small-cell lung cancer. [electronic resource]
Producer: 20141201Description: e33-5 p. digitalISSN:- 1938-0690
- Aged
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Lung Diseases, Interstitial -- chemically induced
- Lung Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyridines -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.